American Origin Unverified
This profile is unclaimed and has not been independently reviewed.
Claim & get verified
NuCana plc
$8.1MMarket cap
12Employees
NCNANASDAQ
2017IPO
About NuCana plc
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States and the United Kingdom.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Reported figures
Financial summary
- Market cap
- $8.1M
- Market cap
- $8.1M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Sep 28, 2017
Market data by Polygon.io · prices are 15-minute delayed
No reviews yet. Be the first to review NuCana plc.
Write a review
Explore
Browse all →
